Email this article to a friend
Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study
Arthritis Research & Therapy 2011, 13:R53 doi:10.1186/ar3297
